170 related articles for article (PubMed ID: 23410905)
1. CT-based response assessment of advanced gastrointestinal stromal tumor: dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria.
Meyer M; Hohenberger P; Apfaltrer P; Henzler T; Dinter DJ; Schoenberg SO; Fink C
Eur J Radiol; 2013 Jun; 82(6):923-8. PubMed ID: 23410905
[TBL] [Abstract][Full Text] [Related]
2. Contrast-enhanced dual-energy CT of gastrointestinal stromal tumors: is iodine-related attenuation a potential indicator of tumor response?
Apfaltrer P; Meyer M; Meier C; Henzler T; Barraza JM; Dinter DJ; Hohenberger P; Schoepf UJ; Schoenberg SO; Fink C
Invest Radiol; 2012 Jan; 47(1):65-70. PubMed ID: 21934517
[TBL] [Abstract][Full Text] [Related]
3. Dual-Energy CT Vital Iodine Tumor Burden for Response Assessment in Patients With Metastatic GIST Undergoing TKI Therapy: Comparison With Standard CT and FDG PET/CT Criteria.
Meyer M; Hohenberger P; Overhoff D; Bartsch A; Henzler T; Haubenreisser H; Ronald J; Schmidt B; Flohr T; Sedlmair M; Ota H; Messiou C; Schoenberg SO; Riedel RF; Nelson RC; Marin D
AJR Am J Roentgenol; 2022 Apr; 218(4):659-669. PubMed ID: 34668385
[No Abstract] [Full Text] [Related]
4. Comparison of RECIST and Choi criteria for computed tomographic response evaluation in patients with advanced gastrointestinal stromal tumor treated with sunitinib.
Dudeck O; Zeile M; Reichardt P; Pink D
Ann Oncol; 2011 Aug; 22(8):1828-33. PubMed ID: 21289369
[TBL] [Abstract][Full Text] [Related]
5. The benefit of using CT-perfusion imaging for reliable response monitoring in patients with gastrointestinal stromal tumor (GIST) undergoing treatment with novel targeted agents.
Betz M; Kopp HG; Spira D; Claussen CD; Horger M
Acta Radiol; 2013 Sep; 54(7):711-21. PubMed ID: 23761542
[TBL] [Abstract][Full Text] [Related]
6. Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy.
Liu K; Li G; Fan C; Zhou C; Li J
Acta Radiol; 2012 Mar; 53(2):127-34. PubMed ID: 22156007
[TBL] [Abstract][Full Text] [Related]
7. Dual energy CT for monitoring targeted therapies in patients with advanced gastrointestinal stromal tumor: initial results.
Schramm N; Schlemmer M; Englhart E; Hittinger M; Becker C; Reiser M; Berger F
Curr Pharm Biotechnol; 2011 Apr; 12(4):547-57. PubMed ID: 21342100
[TBL] [Abstract][Full Text] [Related]
8. Tumor response and clinical outcome in metastatic gastrointestinal stromal tumors under sunitinib therapy: comparison of RECIST, Choi and volumetric criteria.
Schramm N; Englhart E; Schlemmer M; Hittinger M; Übleis C; Becker CR; Reiser MF; Berger F
Eur J Radiol; 2013 Jun; 82(6):951-8. PubMed ID: 23518148
[TBL] [Abstract][Full Text] [Related]
9. Quantitative therapy response assessment by volumetric iodine-uptake measurement: initial experience in patients with advanced hepatocellular carcinoma treated with sorafenib.
Dai X; Schlemmer HP; Schmidt B; Höh K; Xu K; Ganten TM; Ganten MK
Eur J Radiol; 2013 Feb; 82(2):327-34. PubMed ID: 23246016
[TBL] [Abstract][Full Text] [Related]
10. Comparison of performance of various tumor response criteria in assessment of sunitinib activity in advanced gastrointestinal stromal tumors.
Shinagare AB; Barysauskas CM; Braschi-Amirfarzan M; O'Neill AC; Catalano PJ; George S; Ramaiya NH
Clin Imaging; 2016; 40(5):880-4. PubMed ID: 27179958
[TBL] [Abstract][Full Text] [Related]
11. Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.
Choi H; Charnsangavej C; Faria SC; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Benjamin RS
J Clin Oncol; 2007 May; 25(13):1753-9. PubMed ID: 17470865
[TBL] [Abstract][Full Text] [Related]
12. We should desist using RECIST, at least in GIST.
Benjamin RS; Choi H; Macapinlac HA; Burgess MA; Patel SR; Chen LL; Podoloff DA; Charnsangavej C
J Clin Oncol; 2007 May; 25(13):1760-4. PubMed ID: 17470866
[TBL] [Abstract][Full Text] [Related]
13. High-grade soft-tissue sarcomas: tumor response assessment--pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria.
Stacchiotti S; Collini P; Messina A; Morosi C; Barisella M; Bertulli R; Piovesan C; Dileo P; Torri V; Gronchi A; Casali PG
Radiology; 2009 May; 251(2):447-56. PubMed ID: 19261927
[TBL] [Abstract][Full Text] [Related]
14. Objective and subjective image quality of liver parenchyma and hepatic metastases with virtual monoenergetic dual-source dual-energy CT reconstructions: an analysis in patients with gastrointestinal stromal tumor.
Sudarski S; Apfaltrer P; Nance JW; Meyer M; Fink C; Hohenberger P; Leidecker C; Schoenberg SO; Henzler T
Acad Radiol; 2014 Apr; 21(4):514-22. PubMed ID: 24594421
[TBL] [Abstract][Full Text] [Related]
15. Prognosis assessment in metastatic gastrointestinal stromal tumors treated with tyrosine kinase inhibitors based on CT-texture analysis.
Ekert K; Hinterleitner C; Horger M
Eur J Radiol; 2019 Jul; 116():98-105. PubMed ID: 31153581
[TBL] [Abstract][Full Text] [Related]
16. Hepatic arterial embolization and chemoembolization for imatinib-resistant gastrointestinal stromal tumors.
Kobayashi K; Szklaruk J; Trent JC; Ensor J; Ahrar K; Wallace MJ; Madoff DC; Murthy R; Hicks ME; Gupta S
Am J Clin Oncol; 2009 Dec; 32(6):574-81. PubMed ID: 19636238
[TBL] [Abstract][Full Text] [Related]
17. Early prediction of response to sunitinib after imatinib failure by 18F-fluorodeoxyglucose positron emission tomography in patients with gastrointestinal stromal tumor.
Prior JO; Montemurro M; Orcurto MV; Michielin O; Luthi F; Benhattar J; Guillou L; Elsig V; Stupp R; Delaloye AB; Leyvraz S
J Clin Oncol; 2009 Jan; 27(3):439-45. PubMed ID: 19064982
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for treatment response using dual-energy computed tomography in patients with advanced lung adenocarcinoma.
Hong SR; Hur J; Moon YW; Han K; Chang S; Kim JY; Im DJ; Suh YJ; Hong YJ; Lee HJ; Kim YJ; Choi BW
Eur J Radiol; 2018 Apr; 101():118-123. PubMed ID: 29571784
[TBL] [Abstract][Full Text] [Related]
19. The Application of Iodine Quantitative Information Obtained by Dual-Source Dual-Energy Computed Tomography on Chemoradiotherapy Effect Monitoring for Cervical Cancer: A Preliminary Study.
Jiang C; Yang P; Lei J; Li J; Yan K; Li F; Yan R; Xia L
J Comput Assist Tomogr; 2017; 41(5):737-745. PubMed ID: 28448413
[TBL] [Abstract][Full Text] [Related]
20. Utilizing pre-therapy clinical schema and initial CT changes to predict progression-free survival in patients with metastatic renal cell carcinoma on VEGF-targeted therapy: a preliminary analysis.
Smith AD; Shah SN; Rini BI; Lieber ML; Remer EM
Urol Oncol; 2013 Oct; 31(7):1283-91. PubMed ID: 21956044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
